[Diseases of the paranasal sinuses and their relation to respiratory tract diseases].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D002972:Cleft Palate / Q000150:complications; D003490:Cyanosis / Q000150:complications; D003550:Cystic Fibrosis / Q000150:complications; D005100:Expectorants / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D010254:Paranasal Sinus Diseases / Q000209:etiology*; D012130:Respiratory Hypersensitivity / Q000150:complications; D012141:Respiratory Tract Infections / Q000150:complications*; D012852:Sinusitis / Q000188:drug therapy / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000302:isolation & purification; D013290:Streptococcal Infections / Q000188:drug therapy; D013291:Streptococcus / Q000302:isolation & purification; D007507:Therapeutic Irrigation; D019896:alpha 1-Antitrypsin Deficiency
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005100:Expectorants; D006634:Histamine H1 Antagonists
Erkrankungen der Nasennebenhöhlen und ihre Beziehung zu den Erkrankungen der Luftwege.